Cancer nanomedicine: from drug delivery to imaging

Science Translational Medicine
Edward Kai-Hua Chow, Dean Ho

Abstract

Nanotechnology-based chemotherapeutics and imaging agents represent a new era of "cancer nanomedicine" working to deliver versatile payloads with favorable pharmacokinetics and capitalize on molecular and cellular targeting for enhanced specificity, efficacy, and safety. Despite the versatility of many nanomedicine-based platforms, translating new drug or imaging agents to the clinic is costly and often hampered by regulatory hurdles. Therefore, translating cancer nanomedicine may largely be application-defined, where materials are adapted only toward specific indications where their properties confer unique advantages. This strategy may also realize therapies that can optimize clinical impact through combinatorial nanomedicine. In this review, we discuss how particular materials lend themselves to specific applications, the progress to date in clinical translation of nanomedicine, and promising approaches that may catalyze clinical acceptance of nano.

References

Apr 13, 1992·Biochimica Et Biophysica Acta·M C WoodleD Papahadjopoulos
Jan 1, 1987·Cancer Metastasis Reviews·R K Jain
May 15, 1999·Science·B M DischerD A Hammer
Aug 23, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·V P Torchilin
Apr 4, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey D HartgerinkSamuel I Stupp
Jul 23, 2002·Current Opinion in Chemical Biology·Anil K PatriJames R Baker
Mar 15, 2003·Nature Reviews. Cancer·Erkki Ruoslahti
Apr 15, 2003·Nature Materials·Tatjana PauneskuGayle Woloschak
Dec 18, 2003·Drug Discovery Today·Sanjeeb K Sahoo, Vinod Labhasetwar
Jun 5, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E RyschichJ Schmidt
Jul 21, 2004·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Dhirendra S KattiCato T Laurencin
Nov 3, 2004·Cancer Research·Omid C FarokhzadRobert Langer
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Jan 13, 2005·Journal of the American Chemical Society·Eva TóthLon J Wilson
Apr 14, 2005·Nano Letters·Christopher LooRebekah Drezek
Aug 20, 2005·Science·Craig J Hawker, Karen L Wooley
Oct 20, 2005·Current Opinion in Chemical Biology·Alberto BiancoMaurizio Prato
Dec 6, 2005·Molecular Pharmaceutics·Kumiko AjimaSumio Iijima
Oct 24, 2006·Chemical Society Reviews·Rachel K O'ReillyKaren L Wooley
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shigehisa KitanoHiroshi Shiku
Mar 24, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Jun Sung KimMyung-Haing Cho
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeremy D HeidelMark E Davis
Jun 26, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marie GarinotVéronique Préat
Oct 9, 2007·Nano Letters·Houjin HuangDean Ho
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·George E PeoplesSathibalan Ponniah
Mar 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Pak Kin WongChih-Ming Ho
Aug 15, 2008·Cancer Research·Zhuang LiuHongjie Dai
Jun 27, 2009·Accounts of Chemical Research·Megan E FoxJean M J Fréchet
Aug 18, 2009·ACS Nano·Padmaparna ChaudhuriShiladitya Sengupta
Sep 5, 2009·Nature Protocols·Zhuang LiuHongjie Dai
Oct 24, 2009·Integrative Biology : Quantitative Biosciences From Nano to Macro·Chien-Pin SunChih-Ming Ho
Dec 8, 2009·Cancer Cell·Kazuki N SugaharaErkki Ruoslahti
Dec 30, 2009·Nano Letters·Lisa M ManusThomas J Meade

❮ Previous
Next ❯

Citations

Mar 13, 2014·Nature Communications·Ran MoZhen Gu
Sep 16, 2014·Annales pharmaceutiques françaises·R Ouvinha de OliveiraG Barratt
Dec 17, 2014·Expert Opinion on Drug Delivery·V VaijayanthimalaOlga Shenderova
May 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mattias BjörnmalmFrank Caruso
Jul 6, 2014·Advanced Drug Delivery Reviews·David T Leong, Kee Woei Ng
Dec 31, 2015·Proceedings of the National Academy of Sciences of the United States of America·Vipul GujratiSangyong Jon
Dec 25, 2015·Colloids and Surfaces. B, Biointerfaces·Xiupeng WangNoriko M Tsuji
Jan 8, 2016·Nature Protocols·Eun-Kyung Lim, Bong Hyun Chung
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tuo WeiLing Peng
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·Rong Tong, Daniel S Kohane
Jan 31, 2015·Accounts of Chemical Research·Xiaolian SunXiaoyuan Chen
Nov 20, 2015·Science Translational Medicine·Miles A MillerRalph Weissleder
Dec 15, 2015·Nanomedicine·Vahid Heravi SharghMingtao Liang
Dec 15, 2015·Materials Science & Engineering. C, Materials for Biological Applications·Wararat MonthaWeeraphat Pon-On
Apr 16, 2014·BJU International·Michael MaddoxBenjamin R Lee
Oct 17, 2015·Nanomedicine·Deniz Ali Bölükbas, Silke Meiners
Sep 11, 2014·Nanomedicine·Farooq A Shiekh
Apr 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ashish KulkarniShiladitya Sengupta
Feb 3, 2015·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Katherine M TynerSau L Lee
Jul 26, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Haijuan ZouMin Feng
Aug 8, 2015·Biointerphases·Olga A Shenderova, Gary E McGuire
Jun 27, 2015·ACS Nano·Samir MitragotriChenjie Xu
Apr 12, 2015·The Veterinary Journal·Tzu-Yin LinYuanpei Li
Jul 17, 2015·Biomicrofluidics·M Godoy-GallardoL Hosta-Rigau
Feb 7, 2015·Trends in Molecular Medicine·Xiaoyang XuOmid Farokhzad
Dec 17, 2014·Frontiers in Chemistry·João ConniotTeresa S Barata
May 4, 2016·Advanced Drug Delivery Reviews·Jennifer I HareSimon T Barry
Jun 9, 2016·Advanced Drug Delivery Reviews·Miles A Miller, Ralph Weissleder
Jun 9, 2016·Analytical Chemistry·Anne-Isabelle HenryRichard P Van Duyne
Jun 21, 2016·Nature Communications·Carlos Pérez-MedinaThomas Reiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
Scott E McNeil
Current Opinion in Virology
Vladimir Beljanski, John Hiscott
Annual Review of Medicine
Andrew Z WangOmid C Farokhzad
Expert Opinion on Medical Diagnostics
Michele SignoreEmanuel F Petricoin
© 2021 Meta ULC. All rights reserved